Savannah, GA4 Active Studies

Atrial Fibrillation Clinical Trials in Savannah, GA

Find 4 actively recruiting atrial fibrillation clinical trials in Savannah, GA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
1,844
Enrolling

Recruiting Atrial Fibrillation Studies in Savannah

About Atrial Fibrillation Clinical Trials in Savannah

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 4 atrial fibrillation clinical trials recruiting participants in Savannah, GA. These studies are seeking a combined 1,844 participants. Research is being sponsored by Heart Rhythm Clinical and Research Solutions, LLC, Biosense Webster, Inc., Medtronic Cardiac Ablation Solutions. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Savannah — FAQ

Are there atrial fibrillation clinical trials in Savannah?

Yes, there are 4 atrial fibrillation clinical trials currently recruiting in Savannah, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Savannah?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Savannah research site will contact you about next steps.

Are clinical trials in Savannah free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Savannah studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 4 active trials in Savannah are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated July 22, 2026 from ClinicalTrials.gov